Enclomiphene does not typically raise estrogen in the way its predecessor clomiphene (Clomid) does. In clinical data comparing the two drugs, men on enclomiphene actually saw a slight median decrease in estradiol of about 6 pg/mL, while men on clomiphene saw estradiol climb by roughly 17.5 pg/mL. That said, some men do experience estrogen increases on enclomiphene, and the picture is more nuanced than a simple yes or no.
How Enclomiphene Works
Enclomiphene is a selective estrogen receptor antagonist, meaning it blocks estrogen from binding to receptors in the hypothalamus and pituitary gland. Normally, estrogen signals to the brain that hormone levels are adequate, which dials down the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). By blocking that feedback loop, enclomiphene tricks the brain into producing more LH and FSH, which in turn stimulates the testes to make more testosterone.
This is the same basic mechanism as clomiphene (Clomid), but with an important distinction. Clomiphene is a mix of two mirror-image molecules: enclomiphene (the anti-estrogenic isomer) and zuclomiphene (which actually activates estrogen receptors). Zuclomiphene also has a much longer half-life, so it accumulates in the body over time. Enclomiphene on its own strips away that estrogenic component, which is why it produces a cleaner hormonal profile with less estrogen stimulation.
What the Clinical Data Shows
A study of 66 men published in Translational Andrology and Urology directly compared hormonal changes between clomiphene and enclomiphene. Men on enclomiphene had a median testosterone increase of 166 ng/dL, while their estradiol dropped by a median of about 6 pg/mL. Men on clomiphene saw a smaller testosterone gain of 98 ng/dL but had their estradiol rise by 17.5 pg/mL. The difference in estradiol response between the two drugs was statistically significant.
However, not all data points in the same direction. A separate analysis presented in The Journal of Urology found that enclomiphene therapy over 12 months resulted in “more significant and sustained increases” in both testosterone and estrogen compared to testosterone gel. In that study, men on enclomiphene went from a baseline testosterone of about 216 ng/dL to 450 ng/dL at 12 months, and estrogen rose alongside it. This makes physiological sense: when testosterone goes up substantially, some of it naturally converts to estrogen through a process called aromatization. The higher your testosterone climbs, the more raw material exists for estrogen production.
Why Some Men Still Get Estrogen Spikes
The degree to which testosterone converts to estrogen varies from person to person. Men with higher body fat tend to aromatize more, because fat tissue contains the enzyme responsible for that conversion. So while enclomiphene itself doesn’t directly stimulate estrogen production, the testosterone increase it causes can lead to a secondary rise in estrogen for some individuals.
In one clinical series of 11 men on enclomiphene, 4 required either an aromatase inhibitor or tamoxifen due to elevated estradiol levels or the development of gynecomastia (breast tissue growth). That’s a notable proportion, roughly one in three, suggesting estrogen-related side effects aren’t rare even with the “cleaner” isomer. Interestingly, the researchers in that study noted that blocking estrogen action also blunted the rise in IGF-1 (a growth factor) that enclomiphene otherwise produced, hinting at trade-offs when adding estrogen-blocking medications.
Enclomiphene vs. Clomiphene for Estrogen
The practical advantage of enclomiphene over traditional clomiphene comes down to the absence of zuclomiphene. Because zuclomiphene activates estrogen receptors and lingers in the body, men taking standard Clomid often experience estrogen-related side effects like mood changes, water retention, and breast tenderness. Enclomiphene produces a more favorable testosterone-to-estrogen ratio: testosterone goes up meaningfully while estrogen stays relatively flat or rises only modestly.
In the head-to-head comparison, the difference was stark. Clomiphene pushed estradiol up by a median of 17.5 pg/mL while enclomiphene nudged it down by about 6 pg/mL. For men who are specifically concerned about estrogen-related side effects, this is the key selling point of enclomiphene over its mixed-isomer predecessor.
What This Means in Practice
If you’re taking enclomiphene to raise testosterone, you’re less likely to experience a problematic estrogen spike compared to clomiphene, but you’re not immune. The stronger your testosterone response, the more estrogen your body may produce through natural conversion. Factors like body composition, individual enzyme activity, and dosage all influence where your estradiol lands.
Monitoring bloodwork is the only reliable way to know what’s happening with your estrogen levels on enclomiphene. A baseline estradiol level before starting treatment, followed by periodic checks, gives you and your provider a clear picture of whether estrogen is creeping into a range that warrants attention. Some men stay well within normal estradiol range throughout treatment. Others, particularly those with higher body fat or a strong testosterone response, may see estradiol rise enough to cause symptoms like nipple sensitivity, mood shifts, or fluid retention.